The practice of using a domestic antiviral drug in the etiotropic therapy of acute respiratory viral infection
Aim.Evaluation of efficacy, safety, tolerability, and determination of the optimal dose of riamilovir in patients diagnosed with acute respiratory viral infection (ARVI). Materials and methods.The study included 270 patients with uncomplicated ARVI of mild and moderate severity (with a laboratory...
Main Authors: | D. A. Lioznov, I. I. Tokin, T. G. Zubkova, P. V. Sorokin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
"Consilium Medicum" Publishing house
2020-12-01
|
Series: | Терапевтический архив |
Subjects: | |
Online Access: | https://ter-arkhiv.ru/0040-3660/article/viewFile/60288/43459 |
Similar Items
-
A new approach to etiotropic therapy ARVI in children
by: Alebai U. Sabitov, et al.
Published: (2022-12-01) -
Etiotropic therapy and chemoprophylaxis of influenza with neuraminidase inhibitors
by: T. G. Zubkova, et al.
Published: (2020-01-01) -
Clinical efficiency and safety of riamilovir under various dosage regimens for treatment of acute respiratory viral infections in adults
by: Konstantin V. Zhdanov, et al.
Published: (2023-12-01) -
EVOLUTION OF THE ETIOTROPIC TREATMENT OF SHIGELLOSIS
by: V. V. NIKIFOROV, et al.
Published: (2017-05-01) -
New prospects for local etiotropic treatment of acute respiratory viral infections
by: A. A. Krivopalov, et al.
Published: (2019-04-01)